Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Friday, April 22, 2016

Edward Fox from the MS Clinic of Central Texas: Alemtuzumab's Long-Term Studies Show Efficacy for Multiple Sclerosis Treatment -

                                                                  

Click here to receive MS news via e-mail       



    |    Adam Hochron -



With a unique delivery method, alemtuzumab (Lemtrada) has proven to be an effective treatment option for multiple sclerosis. While careful monitoring is required, new data has shown benefits for the right patient population. 


Edward J. Fox, MD, PhD, director of the MS Clinic of Central Texas, discussed the latest research on Lemtrada, which was presented at the 68th Annual Meeting of the American Academy of Neurology in Vancouver. - 





                                            
MS Views and News 
Providing educational information and resources for those affected by MS
Keep current with Multiple Sclerosis news and information 
.===================================

No comments: